NovaBridge Biosciences (NBP) Prepaid Assets (2018 - 2026)
NovaBridge Biosciences (NBP) posted quarterly Prepaid Assets of $6.7 million for Q4 2025, up 102.67% year-over-year from $3.3 million in Q4 2024, and up 48.37% quarter-over-quarter from $4.5 million in Q3 2025.
Analysis
NovaBridge Biosciences (NBP) Prepaid Assets (2018 - 2026) Analysis & Trends
NovaBridge Biosciences (NBP) has reported Prepaid Assets for 8 consecutive years, with $6.7 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Prepaid Assets rose 102.67% year-over-year to $6.7 million; the TTM figure through Dec 2025 stood at $6.7 million (up 102.67% YoY), while the FY2025 annual figure was $6.7 million, up 102.67% from the prior year.
- Prepaid Assets rose to $6.7 million in Q4 2025 per NBP's latest filing, from $4.5 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $29.8 billion in Q4 2021 and bottomed at $2.0 million in Q2 2025.
- Historically, Prepaid Assets has averaged $2.3 billion across 5 years, with a median of $7.2 million in 2023.
- Annual changes were most pronounced in 2021 — Prepaid Assets jumped 101093.59% — and 2022, when it plunged 99.96%.
- NovaBridge Biosciences' Prepaid Assets stood at $29.8 billion in 2021, then slumped by 99.96% to $11.3 million in 2022, then slumped by 36.01% to $7.2 million in 2023, then tumbled by 54.38% to $3.3 million in 2024, then soared by 102.67% to $6.7 million in 2025.
- Business Quant data shows NBP's Prepaid Assets at $6.7 million in Q4 2025, $4.5 million in Q3 2025, and $2.0 million in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | NovaBridge Biosciences | 197.68 Mn | 197.68 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.16 Mn |
| Dec 31, 2025 | 6.68 Mn |
| Sep 30, 2025 | 4.50 Mn |
| Jun 30, 2025 | 2.03 Mn |
| Mar 31, 2025 | 4.61 Mn |
| Dec 31, 2024 | 3.30 Mn |
| Sep 30, 2024 | 3.82 Mn |
| Jun 30, 2024 | 22.99 Mn |
| Dec 31, 2023 | 7.22 Mn |
| Jun 30, 2023 | 14.11 Mn |
| Dec 31, 2022 | 11.29 Mn |
| Jun 30, 2022 | 15.08 Mn |
| Dec 31, 2021 | 29.85 Mn |
| Jun 30, 2021 | 31.04 Mn |
| Dec 31, 2020 | 29.49 Mn |
| Sep 30, 2020 | 32.38 Mn |
| Jun 30, 2020 | 18.56 Mn |
| Dec 31, 2019 | 19.30 Mn |
| Dec 31, 2018 | 12.87 Mn |